MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Neuphoria Therapeutics Inc. (NASDAQ: NEUP)
Organization & Developments: Neuphoria Therapeutics
Parents
Neuphoria Therapeutics Inc. (NASDAQ: NEUP)
Children
*Clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders
*Lead drug candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor for the treatment of social anxiety disorder and post-traumatic stress disorder.
Jumps
Finance & Acquisition: Neuphoria Therapeutics
Key People: Neuphoria Therapeutics